Alpha DNA Investment Management LLC Invests $419,000 in Genpact Limited (NYSE:G)

Alpha DNA Investment Management LLC purchased a new stake in shares of Genpact Limited (NYSE:G - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 9,756 shares of the business services provider's stock, valued at approximately $419,000.

A number of other large investors have also recently added to or reduced their stakes in the business. SRH Advisors LLC purchased a new stake in shares of Genpact during the fourth quarter worth $26,000. Atlas Capital Advisors Inc. increased its holdings in Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after purchasing an additional 216 shares during the period. Manchester Capital Management LLC acquired a new stake in Genpact in the 4th quarter valued at about $38,000. Smartleaf Asset Management LLC boosted its stake in shares of Genpact by 416.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after buying an additional 783 shares during the period. Finally, UMB Bank n.a. grew its position in shares of Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after buying an additional 433 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the sale, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 2.80% of the company's stock.

Genpact Stock Up 0.5 %

Genpact stock traded up $0.23 during trading on Wednesday, reaching $47.58. 1,397,505 shares of the company's stock were exchanged, compared to its average volume of 1,346,007. Genpact Limited has a 52-week low of $30.38 and a 52-week high of $56.76. The firm has a market cap of $8.36 billion, a price-to-earnings ratio of 16.75, a PEG ratio of 1.84 and a beta of 1.06. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The company's 50-day moving average is $50.19 and its two-hundred day moving average is $46.19.

Genpact (NYSE:G - Get Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were given a dividend of $0.17 per share. This is a boost from Genpact's previous quarterly dividend of $0.15. The ex-dividend date of this dividend was Tuesday, March 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.43%. Genpact's dividend payout ratio (DPR) is presently 23.94%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Mizuho increased their price objective on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and raised their price objective for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Needham & Company LLC increased their target price on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Finally, Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and boosted their price target for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $50.38.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.